SCHEMBL6346153

SCHEMBL6346153

CCc1nc(-c2cc(OC)ccc2OC)c(CC)nc1-c1ccc(OC)cc1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 13/20 0.65
L3MBTL1 Q9Y468 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.47
RECQL P46063 1/20 0.47
CYP1A1 P04798 2/20 0.44
CYP1B1 Q16678 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
POLB P06746 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2E1 P05181 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C8 P10632 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2A6 P11509 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283374 0.94 CRHR1 (0.71) CRHR1CYP1A1CYP1B1CA12CA1
SCHEMBL6347614 0.91 CRHR1 (0.59) CRHR1KDM4E
SCHEMBL6285479 0.91 CRHR1 (0.59) CRHR1L3MBTL1KDM4ECYP1A1CYP1B1
SCHEMBL6346182 0.88 CRHR1 (0.60) CRHR1L3MBTL1KDM4EADORA3
SCHEMBL5412053 0.86 CRHR1 (0.62) CRHR1CYP1A1CYP1B1CYP1A2CYP2E1
SCHEMBL5412011 0.86 CRHR1 (0.66) CRHR1CYP1A1CYP1B1CYP1A2CYP2E1
SCHEMBL6283075 0.85 CRHR1 (0.61) CRHR1L3MBTL1KDM4EMAPK1RECQL
SCHEMBL6281208 0.83 CRHR1 (0.60) CRHR1L3MBTL1KDM4EMAPK1CYP1A1
SCHEMBL6287127 0.83 CRHR1 (0.60) CRHR1CYP1A1CYP1B1CYP1A2CYP2E1
SCHEMBL6285778 0.82 CRHR1 (0.59) CRHR1CYP1A1CYP1B1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176721-A1 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines HUANG JIANHUA (US) 2005-08-11 US claimed
US-20030119844-A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines NEUROGEN CORPORATION 2003-06-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119844-A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines CRHR2, CRHR1, CRH CRHR1 2/4885L3MBTL1 4409/4885KDM4E 3460/4885
US-20050176721-A1 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines CRHR2, CRHR1, CRH CRHR1 2/4885L3MBTL1 4490/4885KDM4E 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.